Survey drills down on the preferences and experiences of site personnel in critical function areas such as site initiation and monitoring, training, sponsor interaction, and patient recruitment and retention.
On Wednesday, DrugDev is debuting its Site Activation Module at the SCOPE Summit. The company believes the module will greatly improve all tasks of site activation, from protocol feasibility, site identification and selection, to contracts and the collection of site regulatory documents.
While several studies and surveys have examined the relationship between sponsors and CROs, there has been little analysis of CRO-investigative site relationships. This study uncovers useful learnings on the positive and negative experiences of investigators in their direct dealings with CROs.
Nimblify, Inc., developer of a patient-centric payment system and a benchmarking tool for sites, among other technologies, will participate as a Global Impact Partner.